Table 2

Quantitation of BM cells at different stages of maturation

BM cellsBCR-ABL, % (n = 6/6, average ± SD)BCR-ABL + H78Q, % (n = 8/10, average ± SD)BCR-ABL + V91fs-ter94, % (n = 3/9, average ± SD)
Myeloblast/promyelocyte 0.7 ± 1.2 22.6 ± 4.9§ 9.3 ± 3.2* 
Late myelocyte/metamyelocyte 16.7 ± 3.2 12.5 ± 8.6 15.3 ± 17.2 
Band neutrophil 78.5 ± 6.2 56.1 ± 14.8§ 66.3 ± 17.6 
Others 4.2 ± 3.3 8.8 ± 6.6 9.0 ± 2.6 
BM cellsBCR-ABL, % (n = 6/6, average ± SD)BCR-ABL + H78Q, % (n = 8/10, average ± SD)BCR-ABL + V91fs-ter94, % (n = 3/9, average ± SD)
Myeloblast/promyelocyte 0.7 ± 1.2 22.6 ± 4.9§ 9.3 ± 3.2* 
Late myelocyte/metamyelocyte 16.7 ± 3.2 12.5 ± 8.6 15.3 ± 17.2 
Band neutrophil 78.5 ± 6.2 56.1 ± 14.8§ 66.3 ± 17.6 
Others 4.2 ± 3.3 8.8 ± 6.6 9.0 ± 2.6 
*

Percentages with statistical significance as compared to the BCR-ABL along group.

P < .05

P < .005

§

P < .0001.

or Create an Account

Close Modal
Close Modal